Abstract | BACKGROUND:
Mucormycosis is a rare fungal infection occurring most frequently in immunocompromised patients. The pathogens are filamentous fungi, order of Mucorales. Disseminated mucormycosis is a severe, life treating disease. Early diagnosis is a major determinant for prognosis, however, it remains difficult. The management consists in an early antifungal therapy using lipid formulation of amphotericin B associated with an extensive surgical debridement. Despite this therapeutic of choice, the mortality of disseminated mucormycosis remains high. OBSERVATION: We report the case of disseminated mucormycosis in a 25 years old woman 9 months after a pulmonary transplantation. The clinical presentation included pulmonary and thyroid localization and the pathogen was Absidia corymbifera. The patient survived thanks to a large surgical debridement, and an early antifungal bitherapy by lipid formulation of amphotericin B and posaconazole. CONCLUSION:
|
Authors | C Minet, A Bonadona, A Tabah, A Karkas, L Mescam, C Schwebel, R Hamidfar, C Pison, C Saint-Raymond, O Faure, D Salameire, J-F Timsit |
Journal | Revue des maladies respiratoires
(Rev Mal Respir)
Vol. 26
Issue 9
Pg. 998-1002
(Nov 2009)
ISSN: 1776-2588 [Electronic] France |
Vernacular Title | Mucormycose disséminée d'évolution favorable chez une greffée pulmonaire. |
PMID | 19953048
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
- Antifungal Agents
- Triazoles
- posaconazole
- Amphotericin B
|
Topics |
- Absidia
- Adult
- Amphotericin B
(administration & dosage)
- Antifungal Agents
(administration & dosage)
- Combined Modality Therapy
- Debridement
- Female
- Humans
- Lung Diseases, Fungal
(diagnosis, surgery)
- Lung Transplantation
- Mucormycosis
(diagnosis, drug therapy, surgery)
- Opportunistic Infections
(diagnosis, drug therapy, surgery)
- Thyroid Diseases
(diagnosis, surgery)
- Triazoles
(administration & dosage)
|